Electromed, Inc. (ELMD)
| Market Cap | 93.76M |
| Revenue (ttm) | 42.32M |
| Net Income (ttm) | 1.95M |
| Shares Out | 8.49M |
| EPS (ttm) | 0.22 |
| PE Ratio | 50.23 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,277 |
| Open | 11.10 |
| Previous Close | 11.29 |
| Day's Range | 11.05 - 11.38 |
| 52-Week Range | 8.75 - 13.25 |
| Beta | 0.51 |
| Analysts | Buy |
| Price Target | 17.09 (+54.66%) |
| Earnings Date | Feb 14, 2023 |
About ELMD
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology... [Read more]
Financial Performance
In 2022, Electromed's revenue was $41.66 million, an increase of 16.51% compared to the previous year's $35.76 million. Earnings were $2.31 million, a decrease of -2.41%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for ELMD stock is "Buy." The 12-month stock price forecast is $17.09, which is an increase of 54.66% from the latest price.
News
Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue i...
Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (“F...
Electromed, Inc. Announces Fiscal 2023 First Quarter Results
NEW PRAGUE, Minn.
Electromed, Inc. to Participate in Two Upcoming Investor Conferences
NEW PRAGUE, Minn.
Electromed, Inc. Schedules its First Quarter Fiscal 2023 Financial Results Conference Call for November 8, 2022 at 5:00 p.m. PT
NEW PRAGUE, Minn.
Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer
NEW PRAGUE, Minn.
Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Issuer Direct 2022 Windy City Roundup
Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Fiscal 2022 Fourth Quarter and Full Year Financial Results
Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Fourth Quarter and Fiscal 2022 Financial Results Conference Call for August 23, 2022 at 5:00 p.m. ET
Electromed, Inc. Announces Election of Andrew Summers as Additional Independent Director
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it has elected a new independent d...
Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
7 Lesser-Known Small-Cap Stocks to Keep on Your Watchlist
These small-cap stocks just might fly underneath the drama yet still pack enormous potential to rise up over the long haul. The post 7 Lesser-Known Small-Cap Stocks to Keep on Your Watchlist appeared ...
Electromed, Inc. Announces Clinical Abstract Poster at ATS Conference: Bronchiectasis Patients Showed Improved Outcomes and Reduction in Healthcare Resource Utilization When Using HFCWO Therapy
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic...
Electromed, Inc. Announces Third Quarter Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Third Quarter Financial Results
Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Sidoti & Co. May Micro Cap Virtual Investor Conference
Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Third Quarter Fiscal 2022 Financial Results Conference Call for May 10, 2022 at 5:00 p.m. ET
Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc., Appoints Christopher Holland Chief Commercial Officer
Electromed, Inc. Announces Second Quarter Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Second Quarter Financial Results
Electromed, Inc. Schedules its Second Quarter Fiscal 2022 Financial Results Conference Call for February 8, 2022 at 5:00 p.m. ET
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its...
Electromed, Inc. (ELMD) Upgraded to Buy: Here's What You Should Know
Electromed, Inc. (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Electromed, Inc. to Participate in the Sidoti December Virtual Micro Cap Investor Conference
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan,...
Bears are Losing Control Over Electromed, Inc. (ELMD), Here's Why It's a 'Buy' Now
Electromed, Inc. (ELMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement amo...
Electromed, Inc. (ELMD) Lags Q1 Earnings Estimates
Electromed, Inc. (ELMD) delivered earnings and revenue surprises of -16.67% and 11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Electromed, Inc. Announces Fiscal 2022 First Quarter Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for ...
Electromed, Inc. (ELMD) Reports Next Week: What Awaits?
Electromed, Inc. (ELMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.